MoleculeDx, Inc.
MoleculeDx, Inc.

@MoleculeDxInc

MoleculeDx, Inc. is a molecular diagnostics company advancing research-driven approaches to cancer detection. Its scientific platform is grounded in more than a decade of peer-reviewed research on cancer-associated fusion genes and fusion transcripts. Through Fusion-detect™ Technology, MoleculeDx focuses on multi-marker molecular analysis and the study of circulating fusion-transcript signals, supporting evidence-based research in hepatocellular carcinoma and other areas of cancer science.
4 Entradas
2 Fotos
0 Videos
Vive en PA,United States
10/16/1976
Actualizaciones Recientes
  • HCC Screening Test: Advanced Fusion Transcript Analysis

    Discover MoleculeDx, Inc.'s HCC screening test, built on research into cancer-associated fusion transcripts. A multi-marker molecular analysis evaluates circulating signals and supports ongoing research in hepatocellular carcinoma assessment.

    For more visit - https://www.moleculedx.com/hcc-screening-test-for-high-risk-patients/
    HCC Screening Test: Advanced Fusion Transcript Analysis Discover MoleculeDx, Inc.'s HCC screening test, built on research into cancer-associated fusion transcripts. A multi-marker molecular analysis evaluates circulating signals and supports ongoing research in hepatocellular carcinoma assessment. For more visit - https://www.moleculedx.com/hcc-screening-test-for-high-risk-patients/
    0 Commentarios ·0 Acciones ·81 Views
  • Liver Cancer Screening Blood Test | MoleculeDx, Inc.

    Explore MoleculeDx, Inc. liver cancer screening blood test research, analyzing cancer-associated fusion-transcript signals through a multi-marker molecular approach. Peer-reviewed HCC studies have evaluated circulating cell-free fusion transcripts and machine-learning models to support liver cancer risk assessment research.

    For more visit - https://www.moleculedx.com/blood-test-for-liver-cancer/
    Liver Cancer Screening Blood Test | MoleculeDx, Inc. Explore MoleculeDx, Inc. liver cancer screening blood test research, analyzing cancer-associated fusion-transcript signals through a multi-marker molecular approach. Peer-reviewed HCC studies have evaluated circulating cell-free fusion transcripts and machine-learning models to support liver cancer risk assessment research. For more visit - https://www.moleculedx.com/blood-test-for-liver-cancer/
    0 Commentarios ·0 Acciones ·125 Views
  • 0 Commentarios ·0 Acciones ·11 Views
  • 0 Commentarios ·0 Acciones ·11 Views
Quizás te interese…
Download the Telestraw App!
Download on the App Store Get it on Google Play
×